Clinical Trial

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated May 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-07-20; most recent amendment 2025-04-26.
Status change: Not Yet Recruiting → Recruiting 2021-03-23
Trial Details
NCT Number NCT04484675
Lead Sponsor Zagazig University
Conditions Pulmonary Hypertension Due to Left Heart Disease
Enrollment 38 participants
Start Date 2023-05-20
Primary Completion 2025-05-10 (estimated)
Study Completion 2025-05-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-30